Specific antibody protection of the extracellular cartilage matrix against collagen antibody–induced damage
Open Access
- 29 October 2010
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (11) , 3374-3384
Abstract
Objective: The type II collagen (CII)–specific monoclonal antibodies (mAb) M2139 and CIIC1 induce arthritis in vivo and degrade bovine cartilage explants in vitro, whereas mAb CIIF4 is nonarthritogenic and prevents arthritis development when given in combination with M2139 and CIIC1. To determine the nature of the protective capacity of CIIF4 antibody, we examined the effects of adding CIIF4 to cartilage explants cultured in vitro with M2139 and CIIC1.Methods: Bovine cartilage explants were cultured in the presence of M2139 and CIIC1, with or without CIIF4. Histologic changes were examined, and chemical changes to collagens and proteoglycans were assessed by Fourier transform infrared microspectroscopy (FTIRM). Fresh cartilage and cartilage that had been freeze‐thawed to kill chondrocytes cultured with or without the addition of GM6001, a broad‐spectrum inhibitor of matrix metalloproteinases (MMPs), were compared using FTIRM analysis.Results: M2139 and CIIC1 caused progressive degradation of the cartilage surface and loss of CII, even in the absence of viable chondrocytes. CIIF4 did not cause cartilage damage, and when given with the arthritogenic mAb, it prevented their damage and permitted matrix regeneration, a process that required viable chondrocytes. Inhibition of MMP activity reduced cartilage damage but did not mimic the effects of CIIF4.Conclusion: CII‐reactive antibodies can cause cartilage damage or can be protective in vivo and in vitro, depending on their epitope specificity. Since CII antibodies of similar specificity also occur in rheumatoid arthritis in humans, more detailed studies should unravel the regulatory mechanisms operating at the effector level of arthritis pathogenesis.Keywords
This publication has 43 references indexed in Scilit:
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisJournal of Experimental Medicine, 2009
- Therapeutic cleavage of IgG: new avenues for treating inflammationTrends in Immunology, 2008
- Arthritogenic antibodies specific for a major type II collagen triple‐helical epitope bind and destabilize cartilage independent of inflammationArthritis & Rheumatism, 2007
- Blocking of experimental arthritis by cleavage of IgG antibodies in vivoArthritis & Rheumatism, 2007
- A novel method for determination of collagen orientation in cartilage by Fourier transform infrared imaging spectroscopy (FT-IRIS)Osteoarthritis and Cartilage, 2005
- Arthritogenic anti–type II collagen antibodies are pathogenic for cartilage‐derived chondrocytes independent of inflammatory cellsArthritis & Rheumatism, 2005
- An arthritogenic monoclonal antibody to type II collagen, CII‐C1, impairs cartilage formation by cultured chondrocytesImmunology & Cell Biology, 2004
- Imaging of colorectal adenocarcinoma using FT-IR microspectroscopy and cluster analysisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Reactivity of monoclonal anti‐type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritisArthritis & Rheumatism, 1986
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980